Considerations in the Management of Metabolic Acidosis in Chronic Kidney Disease
On-Demand Webcast
FACULTY
James J. Matera DO, FACOI, FASN
Sr. VP of Medical Affairs and Chief Medical Officer
CentraState Medical Center
Freehold, New Jersey
LEARNING OBJECTIVES
After participating in this activity, participants should be better able to:
- Outline the implications of metabolic acidosis in CKD
- Discuss benefits and risks of various treatment approaches for metabolic acidosis, including the effects of alkali therapy
- Summarize efficacy and safety data of a novel, sodium-free, and nonabsorbable gastrointestinal hydrochloric acid binder
CLAIMING CREDIT
To be eligible for credit, participants must complete the online activity, a post-test assessment, and the evaluation by March 25, 2021. Upon completing the activity, there will be instructions on how to print a certificate or other documentation of credit.
Release Date: March 25, 2020
Expiration Date: March 25, 2021
Estimated Time to Complete: 1 hour
There is no fee associated with this activity.
